Patients of uveitis more likely to develop IBD, finds study
According to a recent study, patient with uveitis have a much higher chance of acquiring inflammatory bowel disease (IBD) than those who do not have uveitis.
Uveitis is an inflammation of the eye's uveal tract. Anatomic locations of involvement are used to classify subtypes, which include anterior (iris and ciliary body), posterior (choroid and retina), intermediate (pars plana), and pan uveitis (generalized inflammation). IBD includes Crohn's disease (CD) and ulcerative colitis, which are chronic idiopathic autoimmune enteropathies (UC).
The following study was done by Tzu-Chen Lo and his team and they focused their work on to look at the possibility of a link between uveitis and an increased risk of developing IBD. The following study and its data were published in Nature Journal on 21 June, 2021.
This was a retrospective cohort research that looked at data from the Taiwan National Health Insurance Research Database between January 1, 2001 and December 31, 2013 to find uveitis patients and age- and gender-matched controls. The two groups' cumulative incidence rates of future IBD were compared. A multivariate cox regression model was used to calculate the adjusted hazard ratio (HR) of IBD linked to uveitis after adjusting for hypertension, diabetes, hyperlipidemia, obesity, and smoking. In addition, the HRs for Crohn's disease (CD) and ulcerative colitis (UC) IBD subtypes were computed individually.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.